ACVR2A (N-term) Peptide
产品名称: ACVR2A (N-term) Peptide
英文名称: ACVR2A (N-term) Peptide
产品编号: P2244
产品价格: 0
产品产地: 台湾
品牌商标: Abnova
更新时间: null
使用范围: null
亚诺法生技股份有限公司(Abnova)
- 联系人 :
- 地址 : 台湾台北市内湖区洲子街 108 号 9 楼
- 邮编 : 11493
- 所在区域 : 台湾
- 电话 : +886-920**1152 点击查看
- 传真 : 点击查看
- 邮箱 : sales@abnova.com.tw
- Specification
- Product Description:
- Rabbit polyclonal antibody raised against synthetic peptide of ACVR2A.
- Immunogen:
- A synthetic peptide (conjugated with KLH) corresponding to N-terminus of human ACVR2A.
- Host:
- Rabbit
- Reactivity:
- Human
- Form:
- Liquid
- Purification:
- Ammonium sulfate precipitation
- Storage Buffer:
- In PBS (0.09% sodium azide)
- Storage Instruction:
- Store at 4°C. For long term storage store at -20°C.
Aliquot to avoid repeated freezing and thawing.
- Recommend Usage:
- ELISA (1:1000)
Western Blot (1:100-500)
Immunohistochemistry (1:50-100)
The optimal working dilution should be determined by the end user.
- Note:
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Publication Reference
- 1.
- Modulation of noncanonical TGF-?] signaling prevents cleft palate in Tgfbr2 mutant mice.
Iwata J, Hacia JG, Suzuki A, Sanchez-Lara PA, Urata M, Chai Y.J Clin Invest. 2012 Mar 1;122(3):873-85. doi: 10.1172/JCI61498. Epub 2012 Feb 13.
- 2.
- Loss of activin receptor type 2 protein expression in microsatellite unstable colon cancers.
Jung B, Doctolero RT, Tajima A, Nguyen AK, Keku T, Sandler RS, Carethers JM.Gastroenterology. 2004 Mar;126(3):654-9.
- 3.
- Expression of activin subunits and receptors in the developing human ovary: activin A promotes germ cell survival and proliferation before primordial follicle formation.
Martins da Silva SJ, Bayne RA, Cambray N, Hartley PS, McNeilly AS, Anderson RA.Dev Biol. 2004 Feb 15;266(2):334-45.
- 4.
- Loss of heterozygosity and mutational analyses of the ACTRII gene locus in human colorectal tumors.
Olaru A, Mori Y, Yin J, Wang S, Kimos MC, Perry K, Xu Y, Sato F, Selaru FM, Deacu E, Sterian A, Shibata D, Abraham JM, Meltzer SJ.Lab Invest. 2003 Dec;83(12):1867-71.
- Applications
- Western Blot (Tissue lysate)
- Western blot analysis of ACVR2A polyclonal antibody (Cat # PAB2643) in mouse liver, brain and kidney tissue lysates (35 ug/lane). ACVR2A (arrow) was detected using the purified polyclonal antibody.
- Western Blot (Transfected lysate)
- Western blot analysis of ACVR2A (arrow) using ACVR2A polyclonal antibody (Cat # PAB2643). 293 cell lysates (2 ug/lane) either nontransfected (Lane 1) or transiently transfected with the ACVR2A gene (Lane 2) (Origene Technologies).
- Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)
- Formalin-fixed and paraffin-embedded human hepatocellular carcinoma tissue reacted with ACVR2A polyclonal antibody (Cat # PAB2643) , which was peroxidase-conjugated to the secondary antibody, followed by AEC staining. This data demonstrates the use of this antibody for immunohistochemistry ; clinical relevance has not been evaluated. HC = hepatocarcinoma.
- Entrez GeneID:
- 92
- Protein Accession#:
- NP_001607;P27037
- Gene Name:
- ACVR2A
- Gene Alias:
- ACTRII,ACVR2
- Gene Description:
- activin A receptor, type IIA
- Omim ID:
- 102581
- Gene Ontology:
- Hyperlink
- Gene Summary:
- This gene encodes activin A type II receptor. Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I (I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling; and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. Type II receptors are considered to be constitutively active kinases. [provided by RefSeq
- Other Designations:
- -
- Related Disease
- Breast Neoplasms
- Colon cancer
- Colonic Neoplasms
- Genetic Predisposition to Disease
- Genomic Instability
- Hyperparathyroidism, Secondary
- Neoplasms, Glandular and Epithelial
- Obesity
- Ovarian cancer
- Ovarian Failure, Premature
- Ovarian Neoplasms
- Polycystic Ovary Syndrome
- Pre-Eclampsia
- Prostate cancer
- Prostatic Neoplasms
- Puberty, Delayed
- Puberty, Precocious
- Thrombophilia
- Tobacco Use Disorder